share_log

Salem Investment Counselors Inc. Purchases 3,125 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Salem Investment Counselors Inc. Purchases 3,125 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

塞勒姆投资顾问公司购买了 Intuitive Surgical, Inc.(纳斯达克股票代码:ISRG)的3,125股股票
Financial News Live ·  2023/02/06 00:51

Salem Investment Counselors Inc. raised its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating) by 5.9% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 55,763 shares of the medical equipment provider's stock after purchasing an additional 3,125 shares during the period. Salem Investment Counselors Inc.'s holdings in Intuitive Surgical were worth $10,452,000 as of its most recent filing with the Securities & Exchange Commission.

根据塞勒姆投资顾问公司最近提交给美国证券交易委员会的文件,该公司在第三季度将其在直觉外科公司公司(Sequoia Capital,Inc.)的股票持仓上调了5.9%。该机构投资者在此期间额外购买了3,125股后,持有这家医疗设备提供商的55,763股股票。截至最近提交给美国证券交易委员会的文件,塞勒姆投资顾问公司持有的直觉外科公司股份价值10,452,000美元。

A number of other institutional investors and hedge funds have also bought and sold shares of the company. Bogart Wealth LLC increased its holdings in shares of Intuitive Surgical by 70.1% in the 3rd quarter. Bogart Wealth LLC now owns 148 shares of the medical equipment provider's stock valued at $28,000 after acquiring an additional 61 shares during the period. Larson Financial Group LLC grew its stake in Intuitive Surgical by 196.1% during the 2nd quarter. Larson Financial Group LLC now owns 151 shares of the medical equipment provider's stock valued at $30,000 after purchasing an additional 100 shares during the last quarter. Gleason Group Inc. grew its stake in Intuitive Surgical by 111.1% during the 3rd quarter. Gleason Group Inc. now owns 190 shares of the medical equipment provider's stock valued at $36,000 after purchasing an additional 100 shares during the last quarter. JFS Wealth Advisors LLC lifted its holdings in shares of Intuitive Surgical by 82.5% in the 2nd quarter. JFS Wealth Advisors LLC now owns 188 shares of the medical equipment provider's stock valued at $38,000 after buying an additional 85 shares during the period. Finally, CoreCap Advisors LLC acquired a new position in shares of Intuitive Surgical in the 2nd quarter valued at about $45,000. 81.96% of the stock is owned by institutional investors.

其他一些机构投资者和对冲基金也买卖了该公司的股票。博嘉财富有限责任公司第三季度增持直觉外科公司股份70.1%。博嘉财富有限责任公司现在拥有148股这家医疗设备提供商的股票,价值2.8万美元,在此期间又购买了61股。今年第二季度,拉尔森金融集团对直觉外科公司的持股增加了196.1%。拉尔森金融集团(Larson Financial Group LLC)在上个季度额外购买了100股后,现在拥有151股这家医疗设备提供商的股票,价值3万美元。格里森集团第三季度增持直觉外科公司股份111.1%。格里森集团(Gleason Group Inc.)在上个季度又购买了100股,现在持有190股这家医疗设备供应商的股票,价值3.6万美元。JFS Wealth Advisors LLC在第二季度增持了82.5%的直觉外科公司股票。JFS Wealth Advisors LLC在此期间又购买了85股,现在拥有188股这家医疗设备提供商的股票,价值3.8万美元。最后,CoreCap Advisors LLC在第二季度收购了直觉外科公司的新头寸,价值约45,000美元。81.96%的股票由机构投资者持有。

Get
到达
Intuitive Surgical
直觉外科公司
alerts:
警报:

Analyst Upgrades and Downgrades

分析师升级和下调评级

A number of research firms recently weighed in on ISRG. Mizuho reduced their price target on Intuitive Surgical from $245.00 to $240.00 in a report on Wednesday, January 25th. Morgan Stanley decreased their price target on Intuitive Surgical from $290.00 to $265.00 and set an "equal weight" rating on the stock in a research note on Wednesday, January 25th. Jefferies Financial Group assumed coverage on Intuitive Surgical in a research note on Wednesday, October 12th. They issued a "hold" rating and a $210.00 price objective on the stock. Wells Fargo & Company cut their price target on Intuitive Surgical from $305.00 to $289.00 and set an "overweight" rating on the stock in a research note on Wednesday, January 25th. Finally, Piper Sandler raised their price objective on Intuitive Surgical from $260.00 to $265.00 and gave the stock an "overweight" rating in a report on Wednesday, October 19th. Six investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat.com, Intuitive Surgical presently has an average rating of "Moderate Buy" and a consensus target price of $273.83.

最近,一些研究公司加入了对ISRG的研究。瑞穗在1月25日周三的一份报告中将直觉外科公司的目标价从245.00美元下调至240.00美元。摩根士丹利在1月25日周三的一份研究报告中将直觉外科公司的目标价从290.00美元下调至265.00美元,并对该股设定了“同等权重”的评级。杰富瑞金融集团在10月12日星期三的一份研究报告中对直觉外科公司进行了报道。他们对该股发布了“持有”评级和210.00美元的目标价。富国银行将直觉外科公司的目标价从305.00美元下调至289.00美元,并在1月25日的一份研究报告中对该股设定了“增持”评级。最后,派珀·桑德勒将直觉外科公司的目标股价从260.00美元上调至265.00美元,并在10月19日(周三)的一份报告中给予该股“增持”评级。6名投资分析师对该股的评级为持有,13名分析师对该公司的评级为买入。根据MarketBeat.com的数据,直觉外科公司目前的平均评级为“中等买入”,共识目标价为273.83美元。

Intuitive Surgical Stock Performance

直觉外科公司股票表现

Intuitive Surgical stock traded down $6.22 during trading on Friday, reaching $254.68. 1,691,448 shares of the company's stock were exchanged, compared to its average volume of 2,011,179. The company's 50-day moving average is $262.77 and its two-hundred day moving average is $236.24. Intuitive Surgical, Inc. has a 52-week low of $180.07 and a 52-week high of $308.97. The firm has a market cap of $90.00 billion, a price-to-earnings ratio of 69.58, a PEG ratio of 5.05 and a beta of 1.28.
直觉外科公司的股票在周五的交易中下跌了6.22美元,达到254.68美元。该公司股票成交量为1,691,448股,而其平均成交量为2,011,179股。该公司50日移动均线切入位在262.77美元,200日移动均线切入位在236.24美元。直觉外科公司的股价为180.07美元,为52周低点,52周高点为308.97美元。该公司的市值为90亿美元,市盈率为69.58倍,市盈率为5.05倍,贝塔系数为1.28。

Intuitive Surgical (NASDAQ:ISRG – Get Rating) last announced its quarterly earnings results on Tuesday, January 24th. The medical equipment provider reported $1.23 earnings per share for the quarter, missing analysts' consensus estimates of $1.25 by ($0.02). Intuitive Surgical had a return on equity of 11.27% and a net margin of 21.25%. The business had revenue of $1.66 billion for the quarter, compared to analysts' expectations of $1.66 billion. During the same period last year, the company posted $1.30 earnings per share. The firm's revenue for the quarter was up 6.7% on a year-over-year basis. Analysts anticipate that Intuitive Surgical, Inc. will post 4.22 EPS for the current year.

直觉外科公司(纳斯达克代码:ISRG-GET Rating)上一次公布季度收益是在1月24日(星期二)。这家医疗设备供应商公布本季度每股收益为1.23美元,低于分析师普遍预期的1.25美元(0.02美元)。直觉外科公司的股本回报率为11.27%,净利润率为21.25%。该业务当季营收为16.6亿美元,高于分析师预期的16.6亿美元。去年同期,该公司公布的每股收益为1.30美元。该公司当季营收较上年同期增长6.7%。分析师预计,直觉外科公司公司本年度每股收益将达到4.22欧元。

Insiders Place Their Bets

内部人士下注

In other Intuitive Surgical news, Director Amal M. Johnson sold 6,375 shares of the business's stock in a transaction on Tuesday, November 8th. The shares were sold at an average price of $239.36, for a total value of $1,525,920.00. Following the transaction, the director now owns 11,224 shares in the company, valued at approximately $2,686,576.64. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other Intuitive Surgical news, Director Amal M. Johnson sold 6,375 shares of the business's stock in a transaction on Tuesday, November 8th. The shares were sold at an average price of $239.36, for a total value of $1,525,920.00. Following the transaction, the director now owns 11,224 shares in the company, valued at approximately $2,686,576.64. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Robert Desantis sold 1,629 shares of the business's stock in a transaction on Friday, January 27th. The stock was sold at an average price of $250.00, for a total transaction of $407,250.00. Following the completion of the transaction, the executive vice president now owns 6,769 shares in the company, valued at approximately $1,692,250. The disclosure for this sale can be found here. 0.90% of the stock is currently owned by company insiders.

直觉外科公司的另一则消息是,董事在11月8日(星期二)的一次交易中出售了6,375股该公司的股票。这些股票的平均价格为239.36美元,总价值为1,525,920.00美元。交易完成后,董事现在拥有该公司11,224股股份,价值约2,686,576.64美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的,该文件可通过这个环节。直觉外科公司的另一则消息是,董事在11月8日(星期二)的一次交易中出售了6,375股该公司的股票。这些股票的平均价格为239.36美元,总价值为1,525,920.00美元。交易完成后,董事现在拥有该公司11,224股股份,价值约2,686,576.64美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的,该文件可通过这个环节。此外,执行副总裁罗伯特·德桑蒂斯在1月27日星期五的一次交易中出售了1629股该公司的股票。股票以250.00美元的平均价格出售,总成交金额为407,250.00美元。交易完成后,执行副总裁总裁现在拥有该公司6769股股份,价值约1692,250美元。关于这次销售的披露可以找到这里。公司内部人士目前持有该公司0.90%的股份。

Intuitive Surgical Company Profile

直觉外科公司公司简介

(Get Rating)

(获取评级)

Intuitive Surgical, Inc engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

直觉外科公司公司从事达芬奇外科系统及相关侵入性手术器械和附件的开发、制造和营销。它的产品包括达芬奇和Ion。该公司由弗雷德里克·H·莫尔、约翰·戈登·弗洛因德和罗伯特·G·杨格于1995年11月创立,总部位于加利福尼亚州桑尼维尔。

See Also

另请参阅

  • Get a free copy of the StockNews.com research report on Intuitive Surgical (ISRG)
  • MarketBeat Week in Review – 1/30 – 2/3
  • Are Penny Stocks Worth it? Should You Invest in Penny Stocks?
  • Zimmer Biomet Beats on Earnings, Growth May be Priced In
  • AI Software Maker EPAM Boasts Biggest Tech-Sector Rally
  • Ford Stock Going Forward After Big Earnings Flop
  • 免费获取斯托克新闻网关于直觉外科公司的研究报告
  • 市场回顾周-1/30-2/3
  • 细价股值得吗?你应该投资细价股吗?
  • Zimmer Biomet盈利节节攀升,增长可能被计入价格
  • 人工智能软件制造商EPAM号称科技板块涨幅最大
  • 福特股票在盈利大幅下滑后继续前进

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating).

想看看其他对冲基金持有ISRG吗?访问HoldingsChannel.com获取直觉外科公司股份有限公司(纳斯达克代码:ISRG-GET Rating)的最新13F备案文件和内幕交易信息。

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

接受《直觉外科公司日报》的新闻和评级-在下面输入您的电子邮件地址,即可通过MarketBeat.com的免费每日电子邮件时事通讯接收对直觉外科公司及相关公司的最新新闻和分析师评级的每日摘要。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发